Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: GlaxoSmithKline Biologicals
Woman and Man Max 99 years
GlaxoSmithKline Biologicals
Update Il y a 4 ans
Study to evaluate immunogenicity and safety study of GSK Biologicals’ Herpes Zoster (HZ) vaccine GSK1437173A when co-administered with Pneumovax 23 in adults aged 50 years and older
To determine the vaccine response rate (VRR) to the HZ/su vaccine (based on humoral immune response) one month after the last vaccine dose in the HZ/su – Pneumovax 23 co-administration (Co-Ad) group. ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
GlaxoSmithKline Biologicals S.A
Update Il y a 4 ans
Trial to Assess Long-Term Persistence of Antibodies after GSK Meningococcal ABCWY Vaccination and Response to a Booster in Adolescents
Effectiveness: To evaluate the effectiveness of 3 doses of MenABCWY (administered according to a 0, 2, 6-month schedule) against a randomly selected panel of US endemic N. meningitidis serogroup B in...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
GlaxoSmithKline Biologicals
Update Il y a 4 ans
A phase II open (partially double-blind), randomized, controlled, primary vaccination study to assess the immunogenicity, safety and reactogenicity of one intramuscular dose of four different formulations of GlaxoSmithKline (GSK) Biologicals’ new generations meningococcal serogroups A, C, W-135, Y-tetanus toxoid conjugate (MenACWY-TT) vaccine versus one subcutaneous dose of MENCEVAX™ ACWY in healthy adolescents/young adults aged 15-19 years
To evaluate the immune response induced by four different formulations of GSK Biologicals’ new generations MenACWY-TT candidate conjugate vaccine versus MENCEVAX™ ACWY in healthy adolescents/young adu...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
GlaxoSmithKline Biologicals
Update Il y a 4 ans
A study to test the benefit of a new anti-cancer Treatment in patients with unresectable advanced melanoma Studio per verificare il beneficio di un nuovo trattamento antitumorale in pazienti con melanoma avanzato non operabile
To evaluate the clinical activity of the recMAGE-A3 + AS15 ASCI in terms of the 1-year overall survival rate (OSR) in patients with MAGE-A3 positive, unresectable stage III or stage IV M1a melanoma p...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
GlaxoSmithKline Biologicals
Update Il y a 4 ans
Immunogenicity and reactogenicity of a booster dose of GlaxoSmithKline Biologicals’ GSK2036874A vaccine in healthy toddlers
•To demonstrate the non-inferiority of GSK Biologicals’ DTPw-HBV-IPV(3 doses)/Hib vaccine compared to Poliorix co-administered with Zilbrix/Hib, -(full dose): in terms of seroprotection rates to the...
Country
None
organs
None
Specialty
None
More information
Woman and Man Max 99 years
GlaxoSmithKline Biologicals
Update Il y a 4 ans
A Phase III, open, non-randomized, multi-centric, single dose study to assess mmunogenicity and safety of Fluarix / Influsplit SSW® 2009/2010 injected intramuscularly in young adults (18 to 60 years) and in elderly (over 60 years)
To evaluate the humoral response (anti-hemagglutinin antibody tested by hemagglutination inhibition) against each vaccine strain in adults aged 18 years or above, 21 days after vaccination with Fluari...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
GlaxoSmithKline Biologicals
Update Il y a 4 ans
Immunogenicity and safety of GSK Biologicals’ combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus and Haemophilus influenzae type b (DTPa-IPV/Hib) conjugate vaccine
To assess the immune response to the study vaccine in terms of seroprotection status for diphtheria, tetanus, Hib and poliovirus types 1, 2 and 3 antigens, and in terms of sero-positivity to the pertu...
Country
None
organs
None
Specialty
None
More information
Woman and Man Max 99 years
GlaxoSmithKline Biologicals
Update Il y a 4 ans
A long-term follow-up study (ZOE-LTFU) of two studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to assess the efficacy, safety, and immunogenicity persistence of GSK Biologicals’ Herpes Zoster subunit (HZ/su) vaccine and assessment of 1 or 2 additional doses in two subgroups of older adults
To assess the Vaccine Efficacy (VE) in the prevention of Herpes Zoster (HZ) over the total duration of the ZOSTER-049 (Z49) study overall as measured by the reduction in HZ risk in subjects ≥50 years ...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
GlaxoSmithKline Biologicals
Update Il y a 4 ans
Study to compare the immunogenicity of GlaxoSmithKline Biologicals' thiomersal-free 2-dose Engerix™-B and 3-dose preservative-free Engerix™-B vaccines administered according to a 0, 6 month and 0, 1, 6 month schedule, respectively, and to evaluate safety and reactogenicity of each vaccine in healthy adolescent volunteers (11 to 15 years)
For the primary Epoch: To demonstrate non-inferiority of the immune response induced by (thiomersal-free) Engerix™-B (20 mcg HBsAg) administered as a 2-dose vaccination schedule compared to (preserva...
Country
None
organs
None
Specialty
None
More information
Woman and Man Max 99 years
GlaxoSmithKline Biologicals
Update Il y a 4 ans
A phase IIIb randomised, open, controlled study to assess the safety, reactogenicity and immunogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate vaccine when co-administered with DTPa-combined, MenC and Hib-MenC vaccines in children as a 3-dose primary immunization course during the first 6 months of age
The main objective of the study is to demonstrate that GSK Biologicals’ 10-valent pneumococcal conjugate vaccine, when administered as a 3-dose primary vaccination course, is non-inferior to Prevenar,...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
9
10
11
12
13
14
15
16
17
18
Next